Cytosorbents (CTSO) Misses Q4 EPS by 3c

Cytosorbents (NASDAQ: CTSO) reported Q4 EPS of ($0.07), $0.03 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $9.2 million versus the consensus estimate of $10.57 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Lyntris opens at $15.50, below IPO price of $17.50
• Motorola Solutions (MSI) Declares $1.21 Quarterly Dividend; 1% Yield
• TJX stock drops as profit outlook falls short of analyst estimates